Top 10 at 10: FDA wins on a Friday

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.

 

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

WordPress Table

The FDA has granted Mesoblast’s (ASX:MSB) (NASDAQ:MESO) allogeneic cell therapy, Revascor, a Rare Pediatric Disease (RPD) Designation.

RPD Designation is granted by the FDA for certain serious or life-threatening diseases which primarily affect children.

READ: The next Neuren? These ASX biotech stocks have pending FDA catalysts in 2024

 

LOSERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

WordPress Table

Related Topics

Explore more

Explore more

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

Read The Guide